Enteric formulated indole-3-carboxaldehyde targets the aryl hydrocarbon receptor for protection in a murine model of metabolic syndrome

Publication date: Available online 16 April 2021Source: International Journal of PharmaceuticsAuthor(s): Matteo Puccetti, Marilena Pariano, Monica Borghi, Carolina Barola, Simone Moretti, Roberta Galarini, Paolo Mosci, Maurizio Ricci, Claudio Costantini, Stefano Giovagnoli
Source: International Journal of Pharmaceutics - Category: Drugs & Pharmacology Source Type: research